Myb Antikörper und Ähnliche Produkte
Santa Cruz Biotechnology bietet eine große Auswahl an monoklonalen Myb-Antikörpern für die fortgeschrittene Forschung in der Molekularbiologie. Die monoklonalen Myb-Antikörper eignen sich für Western Blotting (WB), Immunpräzipitation (IP), Immunfluoreszenz (IF), Immunhistochemie mit in Paraffin eingebetteten Schnitten (IHCP), Durchflusszytometrie (FCM) und Enzyme-Linked Immunosorbent Assay (ELISA). Myb-Proteine sind wichtige Regulatoren der Genexpression und haben einen erheblichen Einfluss auf die Zellproliferation, -differenzierung und -apoptose. Das Verständnis der Funktion von Myb ist für die Erforschung der normalen Entwicklung und von Krebs entscheidend, da Myb mit verschiedenen onkogenen Prozessen in Verbindung gebracht wird. Monoklonale Myb-Antikörper ermöglichen den präzisen Nachweis und die Analyse von Myb-Expressionsmustern in verschiedenen zellulären Umgebungen. Forscher können Myb-Protein-Interaktionen und Signalwege mit Hilfe verschiedener experimenteller Ansätze effektiv verfolgen. Moderne Visualisierungstechniken mit monoklonalen Myb-Antikörpern ermöglichen eine detaillierte Untersuchung der Proteinlokalisierung und -dynamik. Die monoklonalen Antikörper von Santa Cruz Biotechnology unterstützen Forscher auf der ganzen Welt dabei, unser Verständnis von zellulären Prozessen und potenziellen therapeutischen Strategien zu verbessern.
Siehe auch...
Learn more about our ImmunoCruz® Antibody Conjugates and Cruz Marker™ MW Standards Promotional
Myb Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
A-Myb Antikörper (D-12) | sc-514682 | mouse IgM κ | 58-75 (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
B-Myb Antikörper (C-5) | sc-390198 | mouse IgG2b κ | 586-700 (h) | WB, IP, IF, ELISA | h | 5 | ||
B-Myb Antikörper (MYBAD10A) | sc-81192 | mouse IgG1 | Internal (h) | WB, IP, IF | h | 4 | ||
c-Myb Antikörper (D-7) | sc-74512 | mouse IgG2a κ | 500-640 (h) | WB, IP, IF, ELISA | m, r, h | 20 | ||
v-Myb/c-Myb Antikörper (3H2747) | sc-73248 | mouse IgG2a | FL (h) | WB, IP | m, r, h | neu |
Phospho-Spezifische Myb Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
p-B-Myb Antikörper (H-3) | sc-377500 | mouse IgG2b κ | Thr 490 (m) | WB, IP, IF, ELISA | m, r, h | neu |
Myb CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
A-Myb CRISPR/Cas9 KO Plasmid (h) | sc-404328 | h | Gene Knockout | GFP | 0 | ||
A-Myb CRISPR/Cas9 KO Plasmid (h2) | sc-404328-KO-2 | h | Gene Knockout | GFP | 0 | ||
A-Myb HDR Plasmid (h2) | sc-404328-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
A-Myb Double Nickase Plasmid (h) | sc-404328-NIC | h | Gene Knockout | Puromycin | 0 | ||
A-Myb Double Nickase Plasmid (h2) | sc-404328-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
A-Myb CRISPR/Cas9 KO Plasmid (m) | sc-421767 | m | Gene Knockout | GFP | 0 | ||
A-Myb HDR Plasmid (m) | sc-421767-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
A-Myb Double Nickase Plasmid (m) | sc-421767-NIC | m | Gene Knockout | Puromycin | 0 | ||
A-Myb Double Nickase Plasmid (m2) | sc-421767-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
B-Myb CRISPR/Cas9 KO Plasmid (h) | sc-401318 | h | Gene Knockout | GFP | 0 | ||
B-Myb HDR Plasmid (h) | sc-401318-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
B-Myb Double Nickase Plasmid (h) | sc-401318-NIC | h | Gene Knockout | Puromycin | 0 | ||
B-Myb Double Nickase Plasmid (h2) | sc-401318-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
B-Myb CRISPR/Cas9 KO Plasmid (m) | sc-421768 | m | Gene Knockout | GFP | 0 | ||
B-Myb HDR Plasmid (m) | sc-421768-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
B-Myb Double Nickase Plasmid (m) | sc-421768-NIC | m | Gene Knockout | Puromycin | 0 | ||
B-Myb Double Nickase Plasmid (m2) | sc-421768-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
c-Myb CRISPR/Cas9 KO Plasmid (h2) | sc-400752-KO-2 | h | Gene Knockout | GFP | 1 | ||
c-Myb HDR Plasmid (h2) | sc-400752-HDR-2 | h | Homology Directed Repair | Puromycin | 1 | ||
c-Myb Double Nickase Plasmid (h) | sc-400752-NIC | h | Gene Knockout | Puromycin | 1 | ||
c-Myb Double Nickase Plasmid (h2) | sc-400752-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
c-Myb CRISPR/Cas9 KO Plasmid (m) | sc-421766 | m | Gene Knockout | GFP | 0 | ||
c-Myb HDR Plasmid (m) | sc-421766-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
c-Myb Double Nickase Plasmid (m) | sc-421766-NIC | m | Gene Knockout | Puromycin | 0 | ||
c-Myb Double Nickase Plasmid (m2) | sc-421766-NIC-2 | m | Gene Knockout | Puromycin | 0 |
Myb CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
A-Myb CRISPR Activation Plasmid (h) | sc-404328-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
A-Myb CRISPR Activation Plasmid (h2) | sc-404328-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
A-Myb Lentiviral Activation Particles (h) | sc-404328-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
A-Myb Lentiviral Activation Particles (h2) | sc-404328-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
A-Myb CRISPR Activation Plasmid (m) | sc-421767-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
A-Myb CRISPR Activation Plasmid (m2) | sc-421767-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
A-Myb Lentiviral Activation Particles (m) | sc-421767-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
A-Myb Lentiviral Activation Particles (m2) | sc-421767-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
B-Myb CRISPR Activation Plasmid (h) | sc-401318-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
B-Myb CRISPR Activation Plasmid (h2) | sc-401318-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
B-Myb Lentiviral Activation Particles (h) | sc-401318-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
B-Myb Lentiviral Activation Particles (h2) | sc-401318-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
B-Myb CRISPR Activation Plasmid (m) | sc-421768-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
B-Myb CRISPR Activation Plasmid (m2) | sc-421768-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
B-Myb Lentiviral Activation Particles (m) | sc-421768-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
B-Myb Lentiviral Activation Particles (m2) | sc-421768-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
c-Myb CRISPR Activation Plasmid (h) | sc-400752-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
c-Myb CRISPR Activation Plasmid (h2) | sc-400752-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
c-Myb Lentiviral Activation Particles (h) | sc-400752-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
c-Myb Lentiviral Activation Particles (h2) | sc-400752-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
c-Myb CRISPR Activation Plasmid (m) | sc-421766-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
c-Myb CRISPR Activation Plasmid (m2) | sc-421766-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
c-Myb Lentiviral Activation Particles (m) | sc-421766-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
c-Myb Lentiviral Activation Particles (m2) | sc-421766-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
Myb siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
A-Myb siRNA (h) | sc-29613 | h | Gene Silencing | N/A | 0 | ||
A-Myb shRNA Plasmid (h) | sc-29613-SH | h | Gene Silencing | Puromycin | 0 | ||
A-Myb shRNA (h) Lentivirale Partikel | sc-29613-V | h | Gene Silencing | Puromycin | 0 | ||
A-Myb siRNA (m) | sc-29614 | m | Gene Silencing | N/A | 0 | ||
A-Myb shRNA Plasmid (m) | sc-29614-SH | m | Gene Silencing | Puromycin | 0 | ||
A-Myb shRNA (m) Lentivirale Partikel | sc-29614-V | m | Gene Silencing | Puromycin | 0 | ||
B-Myb siRNA (h) | sc-43523 | h | Gene Silencing | N/A | 1 | ||
B-Myb shRNA Plasmid (h) | sc-43523-SH | h | Gene Silencing | Puromycin | 1 | ||
B-Myb shRNA (h) Lentivirale Partikel | sc-43523-V | h | Gene Silencing | Puromycin | 1 | ||
B-Myb siRNA (m) | sc-43524 | m | Gene Silencing | N/A | 0 | ||
B-Myb shRNA Plasmid (m) | sc-43524-SH | m | Gene Silencing | Puromycin | 0 | ||
B-Myb shRNA (m) Lentivirale Partikel | sc-43524-V | m | Gene Silencing | Puromycin | 0 | ||
B-Myb siRNA (r) | sc-108008 | r | Gene Silencing | N/A | 0 | ||
B-Myb shRNA Plasmid (r) | sc-108008-SH | r | Gene Silencing | Puromycin | 0 | ||
B-Myb shRNA (r) Lentivirale Partikel | sc-108008-V | r | Gene Silencing | Puromycin | 0 | ||
c-Myb siRNA (h) | sc-29855 | h | Gene Silencing | N/A | 9 | ||
c-Myb shRNA Plasmid (h) | sc-29855-SH | h | Gene Silencing | Puromycin | 9 | ||
c-Myb shRNA (h) Lentivirale Partikel | sc-29855-V | h | Gene Silencing | Puromycin | 9 | ||
c-Myb siRNA (m) | sc-29856 | m | Gene Silencing | N/A | 3 | ||
c-Myb shRNA Plasmid (m) | sc-29856-SH | m | Gene Silencing | Puromycin | 3 | ||
c-Myb shRNA (m) Lentivirale Partikel | sc-29856-V | m | Gene Silencing | Puromycin | 3 | ||
c-Myb siRNA (r) | sc-108009 | r | Gene Silencing | N/A | 0 | ||
c-Myb shRNA Plasmid (r) | sc-108009-SH | r | Gene Silencing | Puromycin | 0 | ||
c-Myb shRNA (r) Lentivirale Partikel | sc-108009-V | r | Gene Silencing | Puromycin | 0 |
Myb Oligonucleotides
| Empty Table Header | Produkt | Übereinstimmende Katalognummer | Katalognummer Mutante | Übereinstimmung Mutante | Bindungsstelle | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
c-Myb consensus oligonucleotide | sc-2583 | sc-2584 | 5’-TAC AGG CAT AAC GGT TCC GTA GTG A-3’ | "A"→"T" | 8 |